Found 133 clinical trials
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
treated with systemic chemotherapy.
- 1245 views
- 17 Sep, 2022
- 84 locations
A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2)
treated with systemic chemotherapy.
- 10 views
- 17 Sep, 2022
- 80 locations
Advanced Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
- 138 views
- 08 Nov, 2020
- 1 location
Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer
neoadjuvant chemotherapy. The sooner the systemic chemotherapy is received, the better suppression it has on activity of tumor growth factors. Pre-operative chemotherapy may eliminate tiny metastases. It may
- 7 views
- 25 Feb, 2022
- 1 location
A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis
The primary objective of this study is to determine whether systemic chemotherapy combined with hepatic arterial infusion with floxuridine and dexamethasone can increase the complete resection
- 98 views
- 23 Jan, 2021
- 1 location
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases
. Unfortunately, only 10 - 15% of CRLM are initially considered resectable. The objective response rates (ORR) after current first-line systemic chemotherapy (sys-CT) regimens range from 40 to 80% and complete
- 0 views
- 11 Nov, 2021
- 1 location
PIPAC in Multimodal Therapy for Patients With Oligometastatic Peritoneal Gastric Cancer (PIPAC_VEROne)
Peritoneal Carcinomatosis is the most frequent site of metastases observed in patients with gastric cancer. Current standard treatment for these patients is palliative systemic chemotherapy, but
- 0 views
- 24 Jul, 2022
- 1 location
Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer
RT improves 2-year PFS in those patients than that of historical data (only with other standard salvage treatments as systemic chemotherapy maximum tumor resection).
- 11 views
- 12 Feb, 2022
- 1 location
Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer
compared with the standard systemic chemotherapy (intravenous 5-FU + leucovorin + oxaliplatin [FOLFOX] or oral capecitabine with IV oxaliplatin [XELOX]).
- 0 views
- 08 Nov, 2021
- 3 locations
Systemic Therapy Combined With Thoracic Concurrent Chemoradiotherapy Versus Systemic Therapy Alone in Stage IVB Esophageal Squamous Cell Carcinoma: A Prospective Randomized Phase II Study (EC-CRT-003)
Retrospective studies suggested that the addition of thoracic concurrent chemoradiotherapy to systemic chemotherapy improved the survival and quality of life (QOL) of patients with metastatic
- 0 views
- 19 Sep, 2022
- 1 location